Global Cancer Diagnostics market and Drivers, Restraints, and Opportunities 2018-2024


Globally, cancer is the most emerging disease in recent times. Cervical, breast, liver, blood, kidney, colorectal, pancreatic, ovarian, melanoma, and lung cancers are types of cancers persisting in humans. Diagnosing at early stage can cure the disease and limit the disease severity. Research institutes have the high adoption rate of cancer diagnostic devices due to heavy funding from government and private institutions.

Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression. Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing number of cancer cases, rapidly rise in geriatric population, awareness initiatives by governments, and increasing government funding are major factors driving the market growth. North America accounted for the largest market share in the cancer diagnostics market in 2017, and is expected to retain its dominance throughout the forecast period. The Pulmonary growth section is driving the market, as it is the most common malignancy. Asia Pacific is expected to emerge as the fastest growing region during the forecast period, majorly due to the growing patient pool in India, China, and Japan. Few of the prominent players in the market are Agilent Technologies Inc., GE Healthcare, Thermo Fisher Scientific Inc., Abbott Laboratories, Qiagen N.V., Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Becton Dickinson & Company, Illumina Inc., Koninklijke Philips N.V., Hologic Inc., and C.R. Bard Inc.

The report provides the complete details of various market trends and adoption rate in various segments and across the regions. The major trends, drivers, restraints, and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the cancer diagnostics market.

This report also provides the competitive landscape of the leading players in Global Cancer Diagnostics market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific info required by the users. The customization of the report is available based on countries, vendor profiles, enterprise and vertical wise.

Report Scope:

  • Healthcare Category
    • DIAGNOSTICS
  • Application Type
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Melanoma
    • Others
  • Regions
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

Industry Outlook: Market Trends and Drivers, Restraints, and Opportunities

 

Request for TOC at sales@infoholicresearch.com

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Secondary & Primary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

methodology

Market related information is congregated from both secondary and primary sources. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

For more details on Research Methodology kindly click here to Engage with our Analyst.


Category :


Pages

Tables

Charts

Regions/countries

/

Companies


Enquiry Hours

10